Cited by 561CRISPR and Genetic EngineeringVirus-based gene therapy researchHematopoietic Stem Cell Transplantation

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Targeted genome editing in human repopulating haematopoietic stem cells

Open access

Genovese, Pietro, Schiroli, Giulia, Escobar, Giulia, Di Tomaso, Tiziano, Firrito, Claudia, Calabria, Andrea, Moi, Davide, Mazzieri, Roberta, Bonini, Chiara, Holmes, Michael C., Gregory, Philip D., van der Burg, Mirjam, Gentner, Bernhard, Montini, Eugenio, Lombardo, Angelo, Naldini, Luigi·2014·Nature

DOI 10.1038/nature13420PMC PMC4082311

Open this paper in CoChat — free account

Abstract

Targeted genome editing by artificial nucleases has brought the goal of site-specific transgene integration and gene correction within the reach of gene therapy. However, its application to long-term repopulating haematopoietic stem cells (HSCs) has remained elusive. Here we show that poor permissiveness to gene transfer and limited proficiency of the homology-directed DNA repair pathway constrain gene targeting in human HSCs. By tailoring delivery platforms and culture conditions we overcame these barriers and provide stringent evidence of targeted integration in human HSCs by long-term multilineage repopulation of transplanted mice. We demonstrate the therapeutic potential of our strategy by targeting a corrective complementary DNA into the IL2RG gene of HSCs from healthy donors and a subject with X-linked severe combined immunodeficiency (SCID-X1). Gene-edited HSCs sustained normal haematopoiesis and gave rise to functional lymphoid cells that possess a selective growth advantage over those carrying disruptive IL2RG mutations. These results open up new avenues for treating SCID-X1 and other diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature13420

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Clustal W and Clustal X version 2.0
Larkin, M., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., López, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,598
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Self-citation
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650 · cited 1×
“Artificial endonucleases, such as Zinc Finger Nucleases (ZFNs) 11 , Transcription Activator-Like Effector Nucleases (TALENs) 12 , and RNA-guided nucleases (CRISPR/Cas) 13 brought the possibility of gene targeting within the reach of gene therapy 14,15 .”
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642
Self-citation
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 1×
“Hematopoietic Stem Cells (HSC)-based gene therapy has provided therapeutic benefit in primary immunodeficiencies 1,2 , thalassemia 3 and leukodystrophies 4,5 .”

Flagged first, then by citations

Show all 44 references

Sorted by citations

Items 301–400 of 561

Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 21
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs
Crippa, S., Conti, A., Vavassori, V., Ferrari, S., Beretta, S., Rivis, S., Bosotti, R., Scala, S., Pirroni, S., Hernández, R. J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.08.011 · Cited by 19
Self-citation
Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa
Perdoni, C., Osborn, M. J., & Tolar, J. (2015) · Translational research · doi:10.1016/j.trsl.2015.05.008 · Cited by 20
Genome Editing for Human Gene Therapy
Meissner, T. B., Mandal, P. K., Ferreira, L. M. R., Rossi, D. J., & Cowan, C. A. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00013-1 · Cited by 21
Genome-edited adult stem cells: Next-generation advanced therapy medicinal products
Benabdellah, K., Sánchez-Hernández, S., Aguilar-González, A., Maldonado‐Pérez, N., Gutiérrez-Guerrero, A., Cortijo-Gutierréz, M., Ramos-Hernández, I., Tristán‐Manzano, M., Galindo‐Moreno, P., Herrera, C., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0338 · Cited by 21
Implications of hematopoietic stem cells heterogeneity for gene therapies
Epah, J., & Schäfer, R. (2021) · Gene Therapy · doi:10.1038/s41434-021-00229-x · Cited by 17
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cells
Conti, A., Giannetti, K., Midena, F., Beretta, S., Gualandi, N., Marco, R. D., Carsana, E., Varesi, A., Tavella, T., Alessandrini, L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102157 · Cited by 24
Self-citation
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
Zittersteijn, H. A., Harteveld, C. L., Klaver-Flores, S., Lankester, A. C., Hoeben, R. C., Staal, F. J. T., & Gonçalves, M. A. F. V. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617780 · Cited by 21
In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations
Psatha, N., Paschoudi, K., Παπαδοπούλου, Α., & Yannaki, E. (2022) · Genes · doi:10.3390/genes13122222 · Cited by 24
An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells
Rai, R., Naseem, A., Vetharoy, W., Steinberg, Z., Thrasher, A. J., Santilli, G., & Cavazza, A. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.02.014 · Cited by 19
A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection
Dudek, A. M., Feist, W. N., Sasu, E. J., Luna, S. E., Ben-Efraim, K., Bak, R. O., Cepika, A.-M., & Porteus, M. H. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.03.002 · Cited by 19
Gene therapy for β-thalassemia: current and future options
Hardouin, G., Miccio, A., & Brusson, M. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.12.001 · Cited by 19
Ex vivo expansion of hematopoietic stem cells
Xie, J., & Zhang, C. C. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4895-3 · Cited by 19
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment
Ali, G., Tariq, M. A., Shahid, K., Ahmad, F. J., & Akram, J. (2020) · Gene Therapy · doi:10.1038/s41434-020-0153-9 · Cited by 20
Cell competition, cooperation, and cancer
Marongiu, F., Cheri, S., & Laconi, E. (2021) · Neoplasia · doi:10.1016/j.neo.2021.08.001 · Cited by 19
Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles
Mazurov, D. V., Ramadan, L., & Kruglova, N. A. (2023) · Viruses · doi:10.3390/v15030690 · Cited by 19
Genome editing technologies to fight infectious diseases
Trevisan, M., Palù, G., & Barzon, L. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1400379 · Cited by 18
Integrase deficient lentiviral vector: prospects for safe clinical applications
Yew, C.-H. T., Gurumoorthy, N., Nordin, F., Tye, G. J., Zaman, W. S. W. K., Tan, J. J., & Ng, M. H. (2022) · PeerJ · doi:10.7717/peerj.13704 · Cited by 20
Editing human hematopoietic stem cells: advances and challenges
Bhoopalan, S. V., Yen, J. S., Levine, R. M., & Sharma, A. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.08.003 · Cited by 18
MYB insufficiency disrupts proteostasis in hematopoietic stem cells, leading to age-related neoplasia
Clarke, M. L., Lemma, R. B., Walton, D. S., Volpe, G., Noyvert, B., Gabrielsen, O. S., & Frampton, J. (2023) · Blood · doi:10.1182/blood.2022019138 · Cited by 20
Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders
Allen, D. G., Kalter, N., Rosenberg, M., & Hendel, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051329 · Cited by 18
Lentiviral Hematopoietic Stem Cell Gene Therapy in Inherited Metabolic Disorders
Wagemaker, G. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.102 · Cited by 18
Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor
Falkenhagen, A., Singh, J., Asad, S., Leontyev, D., Read, S., Zúñiga‐Pflücker, J. C., & Joshi, S. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.08.017 · Cited by 17
Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease
Ramadier, S., Chalumeau, A., Félix, T., Othman, N., Aknoun, S., Casini, A., Maule, G., Masson, C., Cian, A. D., Frati, G., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.019 · Cited by 17
Progress toward improved therapies for inborn errors of metabolism
Ginocchio, V. M., & Brunetti‐Pierri, N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv418 · Cited by 19
High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection
Claiborne, D. T., Detwiler, Z., Docken, S. S., Borland, T. D., Cromer, D., Simkhovich, A., Ophinni, Y., Okawa, K., Bateson, T., Chen, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55873-3 · Cited by 16
Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo
Bykonya, A. G., Лавров, А. В., & Smirnikhina, S. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00479-z · Cited by 17
Gene Editing for Inherited Red Blood Cell Diseases
Bustamante, O. Q., Fañanas-Baquero, S., Dessy-Rodríguez, M., Ojeda-Pérez, I., & Segovia, J. C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.848261 · Cited by 20
CRISPR medicine for blood disorders: Progress and challenges in delivery
Gol, T. M., Ureña-Bailén, G., Hou, Y., Sinn, R., Antony, J. S., Handgretinger, R., & Mezger, M. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.1037290 · Cited by 16
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing
Castiello, M. C., Ferrari, S., & VILLA, A. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101731 · Cited by 16
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells
Valeri, E., Unali, G., Piras, F., Alezz, M. A., Pais, G., Benedicenti, F., Lidonnici, M. R., Cuccovillo, I., Castiglioni, I., Arévalo, S., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.11.020 · Cited by 17
Self-citation
Salient Features of Endonuclease Platforms for Therapeutic Genome Editing
Certo, M. T., & Morgan, R. A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.21 · Cited by 17
Treating hemoglobinopathies using gene-correction approaches: promises and challenges
Cottle, R. N., Lee, C. M., & Bao, G. (2016) · Human Genetics · doi:10.1007/s00439-016-1696-0 · Cited by 17
CRISPR-Directed In Vitro Gene Editing of Plasmid DNA Catalyzed by Cpf1 (Cas12a) Nuclease and a Mammalian Cell-Free Extract
Sansbury, B. M., Wagner, A. M., Nitzan, E., Tarcic, G., & Kmiec, E. B. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0006 · Cited by 16
Genetic Strategies for HIV Treatment and Prevention
Falkenhagen, A., & Joshi, S. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.018 · Cited by 16
Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9
Byambaa, S., Uosaki, H., Ohmori, T., Hara, H., Endo, H., Nureki, O., & Hanazono, Y. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.01.001 · Cited by 15
Preferential Expansion of Human CD34 + CD133 + CD90 + Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy
Christopher, A. C., Venkatesan, V., Karuppusamy, K. V., Srinivasan, S., Babu, P., Azhagiri, M. K. K., Chambayil, K., Bagchi, A., Rajendiran, V., Ravi, N. S., et al. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.089 · Cited by 16
Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation
Poletto, É., Colella, P., Vera, L. N. P., Khan, S. A., Tomatsu, S., Baldo, G., & Gomez‐Ospina, N. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.04.009 · Cited by 18
Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy
Baranyi, U., Farkas, A. M., Hock, K., Mahr, B., Linhart, B., Gattringer, M., Focke-Tejkl, M., Petersen, A., Wrba, F., Rülicke, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.028 · Cited by 16
Gene Therapy for Primary Immunodeficiency
Houghton, B. C., & Booth, C. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000509 · Cited by 19
Pluripotent stem cell based gene therapy for hematological diseases
Vanhee, S., & Vandekerckhove, B. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.022 · Cited by 16
Therapeutic genome editing with engineered nucleases
Haas, S. A., Dettmer‐Monaco, V., & Cathomen, T. (2017) · Hämostaseologie · doi:10.5482/hamo-16-09-0035 · Cited by 15
Emerging therapies in β-thalassemia: toward a new era in management
Bou‐Fakhredin, R., Tabbikha, R., Daadaa, H., & Taher, A. T. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1752180 · Cited by 17
A Curative DNA Code for Hematopoietic Defects
Porteus, M. H., Pavel-Dinu, M., & Pai, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.05.002 · Cited by 15
Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives
Huang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
Delivering the Goods for Genome Engineering and Editing
Skipper, K. A., & Mikkelsen, J. G. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.063 · Cited by 16
Stem cell transplantation for the treatment of immunodeficiency in children: current status and hopes for the future
Booth, C., Silva, J., & Veys, P. A. (2016) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1150177 · Cited by 15
Advances of gene therapy for primary immunodeficiencies
Candotti, F. (2016) · F1000Research · doi:10.12688/f1000research.7512.1 · Cited by 15
Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice
Hiramoto, T., Li, L. B., Funk, S. E., Hirata, R. K., & Russell, D. W. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.028 · Cited by 16
CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation
Gabr, H. M., El-Ghamrawy, M., Almaeen, A. H., Abdelhafiz, A. S., Hassan, A., & Sissy, M. H. E. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01876-4 · Cited by 15
Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells
Salisbury-Ruf, C. T., & Larochelle, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030513 · Cited by 15
BAR-Seq clonal tracking of gene-edited cells
Ferrari, S., Beretta, S., Jacob, A., Cittaro, D., Albano, L., Merelli, I., Naldini, L., & Genovese, P. (2021) · Nature Protocols · doi:10.1038/s41596-021-00529-x · Cited by 15
Self-citation
Genetic Manipulation Strategies for β-Thalassemia: A Review
Zakaria, N. A., Bahar, R., Abdullah, W. Z., Yusoff, A. A. M., Shamsuddin, S., Wahab, R. A., & Johan, M. F. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.901605 · Cited by 15
Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities
Adams, S. P., Wilson, M., Harb, E., Fairbanks, L. D., Xu‐Bayford, J., Brown, L., Kearney, L., Madkaikar, M. R., & Gaspar, H. B. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.08.001 · Cited by 15
Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells
Costa, C., Hypolite, G., Bernadin, O., Lévy, C., Cosset, F., Asnafi, V., Macintyre, E. A., Verhoeyen, E., & Tesio, M. (2016) · Leukemia · doi:10.1038/leu.2016.372 · Cited by 14
Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies
Bauer, D. E., Brendel, C., & Fitzhugh, C. D. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.08.014 · Cited by 15
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy
de Morais, C. C. P. D. L., Correia, E. M., Bonamino, M., & de Vasconcelos, Z. F. M. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.020 · Cited by 15
A Novel High-Throughput Screening Platform Reveals an Optimized Cytokine Formulation for Human Hematopoietic Progenitor Cell Expansion
Tarunina, M., Hernandez, D., Kronsteiner, B., Pratt, P., Watson, T., Hua, P., Gullo, F., van der Garde, M., Zhang, Y., Hook, L., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0216 · Cited by 14
Innovative Cell-Based Therapies and Conditioning to Cure RAG Deficiency
VILLA, A. M., Capo, V., & Castiello, M. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607926 · Cited by 14
Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
Murugesan, R., Karuppusamy, K. V., Marepally, S. K., & Thangavel, S. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1148693 · Cited by 15
Severe Combined Immunodeficiency (SCID) and Its New Treatment Modalities
Wadbudhe, A. M., Meshram, R. J., & Tidke, S. C. (2023) · Cureus · doi:10.7759/cureus.47759 · Cited by 13
Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy
Borot, F., Humbert, O., Ehmsen, J. T., Fields, E., Kohli, S., Radtke, S., Swing, K., Pande, D., Enstrom, M., Laszlo, G. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59713-2 · Cited by 17
BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector
Yamamoto, H., Ishimura, M., Ochiai, M., Takada, H., Kusuhara, K., Nakatsu, Y., Tsuzuki, T., Mitani, K., & Hara, T. (2015) · Gene Therapy · doi:10.1038/gt.2015.91 · Cited by 13
Gene therapy for primary immune deficiencies: a Canadian perspective
Xu, X., Tailor, C. S., & Grunebaum, E. (2017) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-017-0184-y · Cited by 14
Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases
Rogers, G. L., & Cannon, P. M. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.008 · Cited by 13
Bone marrow–derived CD34− fraction: A rich source of mesenchymal stromal cells for clinical application
Ingo, D., Redaelli, D., Rossella, V., Perini, O., Santoleri, L., Ciceri, F., Aiuti, A., & Bernardo, M. E. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.08.011 · Cited by 13
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
Li, R., Wang, Q., She, K., Lu, F., & Yang, Y. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00095-y · Cited by 13
A culture platform to study quiescent hematopoietic stem cells following genome editing
Shiroshita, K., Kobayashi, H., Watanuki, S., Karigane, D., Sorimachi, Y., Fujita, S., Tamaki, S., Haraguchi, M., Itokawa, N., Aoyama, K., et al. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100354 · Cited by 12
Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing
Hou, Y., Ureña-Bailén, G., Gol, T. M., Gratz, P. G., Gratz, H. P., Roig‐Merino, A., Antony, J. S., Lamsfus‐Calle, A., Daniel-Moreno, A., Handgretinger, R., et al. (2022) · Genes · doi:10.3390/genes13122348 · Cited by 14
Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies
Feist, W. N., Luna, S. E., Ben-Efraim, K., Interrante, M. V. F., Amorin, A., Johnston, N. M., Bruun, T. U. J., Utz, A., Ghanim, H. Y., Lesch, B. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58371-8 · Cited by 15
Development of a CRISPR/Cas9 system against ruminant animal brucellosis
Karponi, G., Kritas, S. K., Papadopoulou, G., Akrioti, E.-K., Papanikolaou, E., & Petridou, E. (2019) · BMC Veterinary Research · doi:10.1186/s12917-019-2179-z · Cited by 12
Neurogenethics: An emerging discipline at the intersection of ethics, neuroscience, and genomics
Canli, T. (2015) · Applied & Translational Genomics · doi:10.1016/j.atg.2015.05.002 · Cited by 14
From Marrow to Matrix: Novel Gene and Cell Therapies for Epidermolysis Bullosa
Webber, B. R., & Tolar, J. (2015) · Molecular Therapy · doi:10.1038/mt.2015.47 · Cited by 13
Gene Therapy for Primary Immunodeficiency
Houghton, B., & Booth, C. (2021) · UCL Discovery (University College London) · Cited by 12
Current trends in gene therapy to treat inherited disorders of the brain
Matuszek, Ż., Brown, B. L., Yrigollen, C. M., Keiser, M. S., & Davidson, B. L. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.057 · Cited by 13
Clinical trials aimed at HIV cure or remission: new pathways and lessons learned
Schou, M. D., Søgaard, O. S., & Rasmussen, T. A. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2273919 · Cited by 10
100 plus years of stem cell research—20 years of ISSCR
Lendahl, U. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.04.004 · Cited by 17
Gene therapy for inborn error of immunity – current status and future perspectives
Mudde, A. C. A., & Booth, C. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000876 · Cited by 10
Lentivirus technologies for modulation of the immune system
Houghton, B. C., Booth, C., & Thrasher, A. J. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.08.007 · Cited by 12
Clinical Applications of Genome Editing to HIV Cure
Wang, C. X., & Cannon, P. M. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0233 · Cited by 11
Primary T-Cell Immunodeficiencies
Roifman, C. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00035-1 · Cited by 11
Efficient Correction of the Sickle Mutation in Human Hematopoietic Stem Cells Using a Cas9 Ribonucleoprotein ComplexPreprint
DeWitt, M. A., Magis, W., Bray, N., Wang, T., Berman, J. R., Urbinati, F., Muñoz, D. P., Kohn, D. B., Walters, M. C., Carroll, D., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/036236 · Cited by 12
CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome
Ravendran, S., Hernández, S. S., König, S., & Bak, R. O. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.793010 · Cited by 11
Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders
Wal, P., Aziz, N., Singh, C. P., Rasheed, A., Tyagi, L. K., Agrawal, A., & Wal, A. (2024) · Current Gene Therapy · doi:10.2174/0115665232268840231222035423 · Cited by 10
Repair and replace
Fischer, A. (2014) · Nature · doi:10.1038/nature13344 · Cited by 11
Clinical Translation of TALENS: Treating SCID-X1 by Gene Editing in iPSCs
Biffi, A. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.03.009 · Cited by 10
Identification of the minimum requirements for successful haematopoietic stem cell transplantation
Nishi, K., Sakamaki, T., Sadaoka, K., Fujii, M., Takaori‐Kondo, A., Chen, J. Y., & Miyanishi, M. (2021) · British Journal of Haematology · doi:10.1111/bjh.17867 · Cited by 13
Genome Editing of the Blood: Opportunities and Challenges
Porteus, M. H. (2015) · Current Stem Cell Reports · doi:10.1007/s40778-014-0003-z · Cited by 10
The functional relationship between hematopoietic stem cells and developing T lymphocytes
Staal, F. J. T., Wiekmeijer, A., Brugman, M. H., & Pike‐Overzet, K. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12995 · Cited by 13
L-carnitine in a certain concentration increases expression of cell surface marker CD34 and apoptosis in the rat bone marrow CD34+ hematopoietic stem cells.
Fathi, E., Pashutan, M. K., Farahzadi, R., & Charoudeh, H. N. (2021) · PubMed Central · doi:10.22099/ijvr.2021.39045.5677 · Cited by 10
Rare immune diseases paving the road for genome editing-based precision medicine
Pavel-Dinu, M., Borna, Š., & Bacchetta, R. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1114996 · Cited by 10
The Impact of Immunodeficiency on NK Cell Maturation and Function
Vargas‐Hernández, A., & Forbes, L. R. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0836-8 · Cited by 10
Innovative Therapies for Hemoglobin Disorders
Sii-Felice, K., Nègre, O., Brendel, C., Tubsuwan, A., Morel-à-l’Huissier, E., Filardo, C., & Payen, E. (2020) · BioDrugs · doi:10.1007/s40259-020-00439-6 · Cited by 10
Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?
Klaver-Flores, S., Zittersteijn, H. A., Canté-Barrett, K., Lankester, A. C., Hoeben, R. C., Gonçalves, M. A. F. V., Pike‐Overzet, K., & Staal, F. J. T. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.615619 · Cited by 10
A comparison of DNA repair pathways to achieve a site-specific gene modification of the Bruton's tyrosine kinase gene
Gray, D., Santos, J., Keir, A., Villegas, I. J., Maddock, S., Trope, E. C., Long, J. D., & Kuo, C. Y. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.12.014 · Cited by 11
Efficient site-specific integration in CHO-K1 cells using CRISPR/Cas9-modified donors
Kheirandish, M. H., Rahmani, B., Jaliani, H. Z., Barkhordari, F., Mazlomi, M. A., & Davami, F. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08529-8 · Cited by 9
Genome editing for sickle cell disease: still time to correct?
Ceglie, G., Lecis, M., Canciani, G., Algeri, M., & Frati, G. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1249275 · Cited by 14
Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells
Hoban, M. D., Romero, Z. G., Cost, G. J., Mendel, M. C., Holmes, M. C., & Kohn, D. B. (2016) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc05b04s36 · Cited by 9
Self-citation
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
Alzubi, J., Pallant, C., Mussolino, C., Howe, S. J., Thrasher, A. J., & Cathomen, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-12750-4 · Cited by 9
Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
Papa, L., Djedaini, M., & Hoffman, R. (2019) · Journal of Visualized Experiments · doi:10.3791/59532 · Cited by 9

Authors: Genovese, P., Schiroli, G., Escobar, G., Di Tomaso, T., Firrito, C., Calabria, A., Moi, D., Mazzieri, R., Bonini, C., Holmes, M. C., Gregory, P. D., van der Burg, M., Gentner, B., Montini, E., Lombardo, A., & Naldini, L.
Affiliations: The San Raffaele Telethon Institute for Gene Therapy (IT)
Vita-Salute San Raffaele University (IT)
IRCCS Ospedale San Raffaele (IT)
Sangamo BioSciences (United States) (US)
Erasmus MC (NL)
Corresponding author: Naldini, Luigi
ORCID: Genovese, Pietro
Schiroli, Giulia
Escobar, Giulia
Firrito, Claudia
Calabria, Andrea
Moi, Davide
Mazzieri, Roberta
Bonini, Chiara
Holmes, Michael C.
Gregory, Philip D.
van der Burg, Mirjam
Gentner, Bernhard
Montini, Eugenio
Lombardo, Angelo
Naldini, Luigi
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2014-05-28
Volume: 510
Issue: 7504
Pages: 235-240
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature13420
PMC: PMC4082311
OpenAlex: W1995497292
Cited by: 555
References: 44
Citations by year: 2026: 7 · 2025: 20 · 2024: 23 · 2023: 32 · 2022: 42 · 2021: 51 · 2020: 43 · 2019: 50 · 2018: 57 · 2017: 57 · 2016: 71 · 2015: 77 · 2014: 24
FWCI: 28.82
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
PubMed Central (acceptedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
RePEc: Research Papers in Economics (submittedVersion)
Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords: targeted genome editing, hematopoietic stem cells, homology-directed repair, gene targeting, IL2RG, X-linked severe combined immunodeficiency, gene therapy, transgene integration
MeSH terms: Animals, Endonucleases, Fetal Blood, Hematopoiesis, Hematopoietic Stem Cells, Humans, Male, Mutation, Genome, Human, DNA, Complementary, Hematopoietic Stem Cell Transplantation, Gene Targeting, Antigens, CD34, Mice, Targeted Gene Repair, Interleukin Receptor Common gamma Subunit, X-Linked Combined Immunodeficiency Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeted genome editing in human repopulating haematopoietic stem cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks